MEDIROM Healthcare Technologies Inc is a personal services business based in the US. MEDIROM Healthcare Technologies shares (MRM) are listed on the NASDAQ and all prices are listed in US Dollars. MEDIROM Healthcare Technologies employs 171 staff and has a trailing 12-month revenue of around 0.00.
Our top pick for
Beginners
Our top pick for
Experienced Investors
Our top pick for
Large Accounts
| Latest market close | $7.67 |
|---|---|
| 52-week range | $5.46 - $19.80 |
| 50-day moving average | $8.19 |
| 200-day moving average | $8.72 |
| Wall St. target price | N/A |
| PE ratio | N/A |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | $-1.17 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $7.67 from 2021-10-19
| 1 week (2021-10-13) | -13.14% |
|---|---|
| 1 month (2021-09-21) | 6.05% |
| 3 months (2021-07-21) | -12.24% |
| 6 months (2021-04-21) | -14.68% |
| 1 year (2020-10-17) | N/A |
|---|---|
| 2 years (2019-10-17) | N/A |
| 3 years (2018-10-17) | N/A |
| 5 years (2016-10-17) | N/A |
| Revenue TTM | $3.3 billion |
|---|---|
| Gross profit TTM | $429 million |
| Return on assets TTM | -7.64% |
| Return on equity TTM | -98.81% |
| Profit margin | -16.14% |
| Book value | $101.87 |
| Market capitalisation | $39.8 million |
TTM: trailing 12 months
There are currently 146,144 MEDIROM Healthcare Technologies shares held short by investors – that's known as MEDIROM Healthcare Technologies's "short interest". This figure is 672.9% up from 18,909 last month.
There are a few different ways that this level of interest in shorting MEDIROM Healthcare Technologies shares can be evaluated.
MEDIROM Healthcare Technologies's "short interest ratio" (SIR) is the quantity of MEDIROM Healthcare Technologies shares currently shorted divided by the average quantity of MEDIROM Healthcare Technologies shares traded daily (recently around 2.4 million). MEDIROM Healthcare Technologies's SIR currently stands at 0.06. In other words for every 100,000 MEDIROM Healthcare Technologies shares traded daily on the market, roughly 60 shares are currently held short.
To gain some more context, you can compare MEDIROM Healthcare Technologies's short interest ratio against those of similar companies.
However MEDIROM Healthcare Technologies's short interest can also be evaluated against the total number of MEDIROM Healthcare Technologies shares, or, against the total number of tradable MEDIROM Healthcare Technologies shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case MEDIROM Healthcare Technologies's short interest could be expressed as 0.03% of the outstanding shares (for every 100,000 MEDIROM Healthcare Technologies shares in existence, roughly 30 shares are currently held short) or 0.0701% of the tradable shares (for every 100,000 tradable MEDIROM Healthcare Technologies shares, roughly 70 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against MEDIROM Healthcare Technologies.
Find out more about how you can short MEDIROM Healthcare Technologies stock.
We're not expecting MEDIROM Healthcare Technologies to pay a dividend over the next 12 months.
You may also wish to consider:
MEDIROM Healthcare Technologies Inc. provides holistic healthcare services in Japan. It operates in two segments, Relaxation Salon and Digital Preventative Healthcare. The Relaxation Salon segment own, develops, operates, franchises, and supports relaxation salons, which provide finger-pressure style bodywork therapy, stretch therapy, and posture and joint alignment, as well as physical therapy elements; and various individual services, including anti-fatigue therapy, athletic support therapy, slim-down therapy, and reflexology. As of April 30, 2021, this segment operated 301 relaxation salons under the Re. Ra. Ku and Ruam Ruam brand.
Everything we know about the Aura Biosciences IPO, plus information on how to buy in.
Everything we know about the Claros Mortgage Trust IPO, plus information on how to buy in.
Everything we know about the Evotec SE IPO, plus information on how to buy in.
Everything we know about the Delimobil Holding SA IPO, plus information on how to buy in.
Everything we know about the Blue Water Vaccines IPO, plus information on how to buy in.
Everything we know about the Sonendo IPO, plus information on how to buy in.
Everything we know about the FlexEnergy Green Solutions IPO, plus information on how to buy in.
Everything we know about the Stran & Company IPO, plus information on how to buy in.
Everything we know about the Kidpik Corp IPO, plus information on how to buy in.
Everything we know about the Nuvectis Pharma IPO, plus information on how to buy in.